OBJECTIVE: To determine whether or not self-selected walking speed associates with serum biomarkers of cartilage (collagen and proteoglycan) breakdown in anterior cruciate ligament reconstructed (ACLR) individuals. METHODS: Twenty individuals with a history of a primary unilateral ACLR participated in this cross-sectional study. Resting blood was collected from each participant prior to completing 5 walking gait trials at a self-selected comfortable speed. Walking speed was evaluated in a 3-dimensional motion capture laboratory and determined from the velocity of the pelvic center of mass. Sera were assessed for collagen type II cleavage product (C2C) and proteoglycan (aggrecan) concentrations using commercially available specific enzyme-linked immunosorbent assays. Pearson's product-moment (r) and Spearman's (ρ) correlations were used to evaluate associations between walking speed and biomarkers of cartilage breakdown metabolism. Partial correlations were used to determine whether covariates influenced associations between walking speed and biomarkers of cartilage breakdown. RESULTS: ACLR individuals with a slower walking speed demonstrated higher concentrations of serum C2C (r = -0.52, P = 0.02), while there was no significant association between walking speed and aggrecan concentrations (ρ = -0.29, P = 0.31). After accounting for the variance associated with stance phase duration, ACLR individuals with a slower walking speed still demonstrated greater serum C2C concentrations (partial r = -0.53, P = 0.02). CONCLUSION: ACLR individuals who habitually walk slower may experience a greater degree of collagen breakdown, suggesting that walking speed may be a future useful clinical indicator for identifying individuals with higher levels of cartilage breakdown and preradiographic osteoarthritic joint changes.
OBJECTIVE: To determine whether or not self-selected walking speed associates with serum biomarkers of cartilage (collagen and proteoglycan) breakdown in anterior cruciate ligament reconstructed (ACLR) individuals. METHODS: Twenty individuals with a history of a primary unilateral ACLR participated in this cross-sectional study. Resting blood was collected from each participant prior to completing 5 walking gait trials at a self-selected comfortable speed. Walking speed was evaluated in a 3-dimensional motion capture laboratory and determined from the velocity of the pelvic center of mass. Sera were assessed for collagen type II cleavage product (C2C) and proteoglycan (aggrecan) concentrations using commercially available specific enzyme-linked immunosorbent assays. Pearson's product-moment (r) and Spearman's (ρ) correlations were used to evaluate associations between walking speed and biomarkers of cartilage breakdown metabolism. Partial correlations were used to determine whether covariates influenced associations between walking speed and biomarkers of cartilage breakdown. RESULTS: ACLR individuals with a slower walking speed demonstrated higher concentrations of serum C2C (r = -0.52, P = 0.02), while there was no significant association between walking speed and aggrecan concentrations (ρ = -0.29, P = 0.31). After accounting for the variance associated with stance phase duration, ACLR individuals with a slower walking speed still demonstrated greater serum C2C concentrations (partial r = -0.53, P = 0.02). CONCLUSION: ACLR individuals who habitually walk slower may experience a greater degree of collagen breakdown, suggesting that walking speed may be a future useful clinical indicator for identifying individuals with higher levels of cartilage breakdown and preradiographic osteoarthritic joint changes.
Authors: Brian Pietrosimone; Richard F Loeser; J Troy Blackburn; Darin A Padua; Matthew S Harkey; Laura E Stanley; Brittney A Luc-Harkey; Veronica Ulici; Stephen W Marshall; Joanne M Jordan; Jeffery T Spang Journal: J Orthop Res Date: 2017-03-02 Impact factor: 3.494
Authors: Sandra J Shultz; Randy J Schmitz; Kenneth L Cameron; Kevin R Ford; Dustin R Grooms; Lindsey K Lepley; Gregory D Myer; Brian Pietrosimone Journal: J Athl Train Date: 2019-08-28 Impact factor: 2.860
Authors: Matthew S Harkey; Lori Lyn Price; Timothy E McAlindon; Julie E Davis; Alina C Stout; Bing Lu; Ming Zhang; Charles B Eaton; Mary F Barbe; Grace H Lo; Jeffrey B Driban Journal: Arthritis Care Res (Hoboken) Date: 2019-02 Impact factor: 4.794
Authors: Mackenzie M Herzog; Jeffrey B Driban; Nicole M Cattano; Kenneth L Cameron; Timothy W Tourville; Stephen W Marshall; Brian Pietrosimone Journal: J Rheumatol Date: 2017-06-01 Impact factor: 4.666
Authors: Matthew S Harkey; J Troy Blackburn; Anthony C Hackney; Michael D Lewek; Randy J Schmitz; Brian Pietrosimone Journal: Cartilage Date: 2020-09-19 Impact factor: 3.117
Authors: Steven Pfeiffer; Matthew S Harkey; Laura E Stanley; J Troy Blackburn; Darin A Padua; Jeffrey T Spang; Stephen W Marshall; Joanne M Jordan; Randy Schmitz; Daniel Nissman; Brian Pietrosimone Journal: Arthritis Care Res (Hoboken) Date: 2018-07-04 Impact factor: 4.794
Authors: Jacob J Capin; Jack R Williams; Kelsey Neal; Ashutosh Khandha; Laura Durkee; Naoaki Ito; Joshua J Stefanik; Lynn Snyder-Mackler; Thomas S Buchanan Journal: J Orthop Res Date: 2019-11-18 Impact factor: 3.494
Authors: Michael A Samaan; Valentina Pedoia; Matthew S Tanaka; Richard B Souza; C Benjamin Ma; Xiaojuan Li Journal: J Appl Biomech Date: 2022-01-18 Impact factor: 1.833
Authors: Brian Pietrosimone; Matthew K Seeley; Christopher Johnston; Steven J Pfeiffer; Jeffery T Spang; J Troy Blackburn Journal: Med Sci Sports Exerc Date: 2019-02
Authors: Brian Pietrosimone; Hope C Davis-Wilson; Matthew K Seeley; Christopher Johnston; Jeffrey T Spang; R Alexander Creighton; Ganesh M Kamath; J Troy Blackburn Journal: J Athl Train Date: 2021-01-22 Impact factor: 3.824